Ketamine Long Therm Follow Up Study

Followin Ketamine Treatment Clinical Trial

— ket_Fol_Up  

Official title:

Five Years Follow up: Add on Intravenous Ketamine for Major Depressive Disorder

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04238039
• Other study ID #: 5826-18-SMC
• Status: Recruiting
• Start date: December 14, 2019
• Est. completion date: April 1, 2020

Study information

• Verified date: January 2020
• Source: The Chaim Sheba Medical Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Results of the study and of 5 years follow up of depressed patients who participated in the study during 2014-2015. We will locate the participants and will interview them will use the same questionnaires to evaluate their depressive symptoms. We will also measure the time to relapse.

Description:

Anamnestic data will be collected from the patients, in addition, depressive symptoms will be measured using Montgomery Asberg Depression Scale (MADRAS). In addition, the Clinical Global Severity Scale (CGI-S) and Clinical Global Improvement (CGI-I) were performed 2 hours after treatment. In addition, we performed to prolong the time to relapse in this patient.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 16
• Est. completion date: April 1, 2020
• Est. primary completion date: February 1, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A to 90 Years

Eligibility

Inclusion Criteria:

• Participants in the ketamine study

Exclusion Criteria:

-

Related Conditions & MeSH terms

• Depressive Disorder
• Followin Ketamine Treatment

Locations

Country	Name	City	State
Israel	Revital Amiaz	Ramat Gan	RI

Sponsors (1)

Lead Sponsor	Collaborator
The Chaim Sheba Medical Center

Country where clinical trial is conducted

Israel, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Time to relapse	Medications	5 years